| HOME >> MEDICINE >> TECHNOLOGY |
List of Figures
1.2 List of FiguresFigure 1: Pricing and Reimbursement in Oncology, Diseased Population in the Top Seven Countries for Major Types of Cancer (millions), 2010 9Figure 2: Pricing and Reimbursement in Oncology, Age Standardized Cancer Incidence, Top Seven Countries, 2008 10Figure 3: Pricing and Reimbursement in Oncology, Age Standardized Cancer Mortality, Top Seven Countries, 2008 11Figure 4: Pricing and Reimbursement in Oncology, the US, Total Healthcare Expenditure vs. Out-of-Pocket Expenditure (%), 2009 17Figure 5: Pricing and Reimbursement in Oncology, the US, Expenditure for Cancer Care ($bn), 2010 and 2020 19Figure 6: Pricing and Reimbursement in Oncology, the US, Expenditure for Cancer Care in the Top Five Indications ($bn), 2010 and 2020 20Figure 7: Pricing and Reimbursement in Oncology, the US, Estimated Cancer Cases, By Sites, Men (%), 2011 22Figure 8: Pricing and Reimbursement in Oncology, the US, Estimated Cancer Cases, By Sites, Women (%), 2011 23Figure 9: Pricing and Reimbursement in Oncology, Total Per-capita Expenditure on Pharmaceuticals, Top Five Countries of Europe and the US, $PPP, 1990-2009 27Figure 10: Pricing and Reimbursement in Oncology, NHS and Private Composition of Pharmaceutical Expenditure, Italy, %, 2009 28Figure 11: Pricing and Reimbursement in Oncology, Public Pharmaceutical Expenditure, Pharmacies, Growth Rates (%), 2010-2011 32Figure 12: Pricing and Reimbursement in Oncology, Germany, Healthcare Expenditure by Financing Agent, $ per inhabitant, 2007, 2008, 2009 34Figure 13: Pricing and Reimbursement in Oncology, Germany, Structural Reforms by AMNOG, 2011 37Figure 14: Pricing and Reimbursement in Oncology, European Counties, the US and Japan, Total Healthcare Expenditure vs. Out-of-Pocket Expenditure, 2009 39Figure 15: Pricing and Reimbursement in
'/>"/>
| SOURCE Reportlinker Copyright©2012 PR Newswire. All rights reserved |